Undervalued Drug Manufacturer Stocks on NAS March 2025

March 23, 2025

Drug Manufacturers

Drug Manufacturers are engaged in pharmaceutical manufacturing or sale of a diverse line of drug and healthcare products. This industry group also includes companies engaged in the development and discovery of new dugs, and tobacco and cannabis companies.

NASDAQ

The National Association of Securities Dealers Automated Quotations (Nasdaq) located in New York City, is the most active stock exchange by volume in the United States.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Drug Manufacturers stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
UPC Universe Pharmaceuticals 3.44 10.81 213.80 554468 0 0.00 0.0
SXTC China SXT Pharmaceuticals 2.63 7.57 187.76 293058 0 0.00 0.0
ASRT Assertio Holdings 0.72 1.58 117.89 390438 69 0.00 0.0
EVO Evotec 3.48 7.54 116.67 114933 1234 0.00 0.0
EVOK Evoke Pharma 2.81 5.55 97.34 27237 5 0.00 0.0
TXMD TherapeuticsMD 0.89 1.75 96.99 744558 10 0.00 0.0
AMRN Amarin Corp 0.46 0.90 95.93 2004087 188 0.00 0.0
CGC Canopy Gwth 1.10 2.13 93.30 7874350 121 0.00 0.0
AYTU Aytu BioPharma 1.22 2.32 90.11 45786 10 0.00 0.0
INM InMed Pharmaceuticals 2.78 4.68 68.52 27955 2 0.00 0.0
All data provided as at market close March 20, 2025.

Company Details

Universe Pharmaceuticals

UPC:NAS

Close Price

3.44

Our Valuation

10.81

% Difference

213.80

Market Cap ($M)

0

P/E Ratio

0.0

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies.

Access the stockcalc valuation


China SXT Pharmaceuticals

SXTC:NAS

Close Price

2.63

Our Valuation

7.57

% Difference

187.76

Market Cap ($M)

0

P/E Ratio

0.0

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.

Access the stockcalc valuation


Assertio Holdings

ASRT:NAS

Close Price

0.72

Our Valuation

1.58

% Difference

117.89

Market Cap ($M)

69

P/E Ratio

0.0

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Access the stockcalc valuation


Evotec

EVO:NAS

Close Price

3.48

Our Valuation

7.54

% Difference

116.67

Market Cap ($M)

1234

P/E Ratio

0.0

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Evoke Pharma

EVOK:NAS

Close Price

2.81

Our Valuation

5.55

% Difference

97.34

Market Cap ($M)

5

P/E Ratio

0.0

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Access the stockcalc valuation


TherapeuticsMD

TXMD:NAS

Close Price

0.89

Our Valuation

1.75

% Difference

96.99

Market Cap ($M)

10

P/E Ratio

0.0

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories.

Access the stockcalc valuation


Amarin Corp

AMRN:NAS

Close Price

0.46

Our Valuation

0.90

% Difference

95.93

Market Cap ($M)

188

P/E Ratio

0.0

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Access the stockcalc valuation


Canopy Gwth

CGC:NAS

Close Price

1.10

Our Valuation

2.13

% Difference

93.30

Market Cap ($M)

121

P/E Ratio

0.0

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.

Access the stockcalc valuation


Aytu BioPharma

AYTU:NAS

Close Price

1.22

Our Valuation

2.32

% Difference

90.11

Market Cap ($M)

10

P/E Ratio

0.0

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions.

Access the stockcalc valuation


InMed Pharmaceuticals

INM:NAS

Close Price

2.78

Our Valuation

4.68

% Difference

68.52

Market Cap ($M)

2

P/E Ratio

0.0

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Universe Pharmaceuticals and China SXT Pharmaceuticals are the most undervalued Drug Manufacturers stocks on the NAS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-nas-march-2025
Universe Pharmaceuticals $UPC and China SXT Pharmaceuticals $SXTC are the most undervalued Drug Manufacturers stocks on the #NAS. See the full list: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-nas-march-2025
Universe Pharmaceuticals and China SXT Pharmaceuticals are the most undervalued Drug Manufacturers stocks on the NAS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-nas-march-2025

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.